Bystander effects in enzyme/prodrug gene therapy - Commentary

被引：15

作者：

Paillard, F

机构：

来源：

HUMAN GENE THERAPY | 1997年 / 8卷 / 15期

关键词：

D O I：

10.1089/hum.1997.8.15-1733

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1733 / 1735

页数：3

相关论文

共 9 条

[1] Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene
Benedetti, S
Dimeco, F
Pollo, B
Cirenei, N
Colombo, BM
Bruzzone, MG
Cattaneo, E
Vescovi, A
Didonato, S
Colombo, MP
Finocchiaro, G
[J]. HUMAN GENE THERAPY, 1997, 8 (11) : 1345 - 1353
[2] The bystander effect of the nitroreductase CB 1954 enzyme prodrug system is due to a cell-permeable metabolite
Bridgewater, JA
Knox, RJ
Pitts, JD
Collins, MK
Springer, CJ
[J]. HUMAN GENE THERAPY, 1997, 8 (06) : 709 - 717
[3] SELECTIVE KILLING OF CD4+ CELLS HARBORING A HUMAN IMMUNODEFICIENCY VIRUS-INDUCIBLE SUICIDE GENE PREVENTS VIRAL SPREAD IN AN INFECTED CELL-POPULATION
CARUSO, M
KLATZMANN, D
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (01) : 182 - 186
[4] Immune system in suicide-gene therapy
Freeman, SM
Ramesh, R
Marrogi, AJ
[J]. LANCET, 1997, 349 (9044) : 2 - 3
[5] Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir
Joki, T
Nakamura, M
Ohno, T
[J]. HUMAN GENE THERAPY, 1995, 6 (12) : 1507 - 1513
[6] Gene therapy for metastatic malignant melanoma: Evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration
Klatzmann, D
Herson, S
Cherin, P
Chosidow, O
Baillet, F
Bensimon, G
Boyer, O
Salzmann, JL
[J]. HUMAN GENE THERAPY, 1996, 7 (02) : 255 - 267
[7] The TMC worldwide gene therapy enrollment report, end 1996
Marcel, T
Grausz, JD
[J]. HUMAN GENE THERAPY, 1997, 8 (06) : 775 - 800
[8] METABOLIC SUICIDE GENES IN GENE-THERAPY
MULLEN, CA
[J]. PHARMACOLOGY & THERAPEUTICS, 1994, 63 (02) : 199 - 207
[9] CANCER GENE-THERAPY - A BYSTANDER EFFECT USING THE CAP JUNCTIONAL PATHWAY
PITTS, JD
[J]. MOLECULAR CARCINOGENESIS, 1994, 11 (03) : 127 - 130